SuperSonic Imagine is a leading medical imaging brand that has been revolutionizing the field since its establishment in 2005. Based in Aix-en-Provence, France, the company specializes in designing, developing, and marketing cutting-edge medical imaging technologies. The flagship product of SuperSonic Imagine is the Aixplorer® ultrasound system, powered by its innovative UltraFastTM platform.

This state-of-the-art system can capture images a remarkable 200 times faster than traditional ultrasound systems. What sets Aixplorer® apart is its unique ability to image two types of waves: ultrasound waves for exceptional image quality and shear waves, enabling real-time, reliable, non-invasive visualization and analysis of tissue stiffness. This groundbreaking technology, known as ShearWave TM Elastography, has significantly enhanced the detection and characterization of various pathologies in applications such as breast, thyroid, liver, and prostate imaging.

SuperSonic Imagine has obtained regulatory clearances for the commercialization of Aixplorer® on major markets, affirming its commitment to delivering innovative solutions to healthcare professionals worldwide. Backed by prestigious investors like Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital, and NBGI, SuperSonic Imagine continues to push the boundaries of medical imaging, improving patient care and diagnostic accuracy